Ansell Ltd (ASX: ANN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Ansell Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Ansell Ltd (ASX: ANN)
Latest News
Healthcare Shares
Ansell shares tumble to a 3-month low. Is this a buying opportunity?
Share Fallers
Why Ansell, Elsight, Ramelius, and SGH shares are falling today
Healthcare Shares
$5 billion ASX 200 healthcare stock tumbling on CEO exit
Share Market News
Ansell announces CEO transition: Nathalie Ahlström to succeed Neil Salmon in 2026
Share Market News
Analysts name 2 top ASX 200 shares to buy today
Share Gainers
Why Ansell, Boss Energy, Cedar Woods, and Nick Scali shares are charging higher
Healthcare Shares
Ansell shares surge 6% on AGM and trading update
Share Market News
What's Macquarie's top pick for the third week of AGM season?
Share Market News
Ansell reports data breach: October 2025 update
Broker Notes
Hold 'em, don't fold 'em: 2 ASX 200 shares to hold but not buy anew
Best Shares
ASX stock picks from Australia's top fund managers
Share Market News
These 4 ASX 200 shares were earnings season winners. Should you buy?
Frequently Asked Questions
-
Yes, Ansell has historically paid two unfranked or partially franked dividends per year.
-
Ansell pays its shareholder dividends in March and September.
-
Ansell Ltd listed on the ASX on 22 August 1985.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 29 Aug 2025 | $0.4279 | 0.00% | Final | 18 Sep 2025 |
| 14 Feb 2025 | $0.3486 | 0.00% | Interim | 06 Mar 2025 |
| 26 Aug 2024 | $0.3227 | 0.00% | Final | 12 Sep 2024 |
| 26 Feb 2024 | $0.2521 | 0.00% | Interim | 14 Mar 2024 |
| 18 Aug 2023 | $0.4031 | 0.00% | Final | 07 Sep 2023 |
| 20 Feb 2023 | $0.2915 | 0.00% | Interim | 09 Mar 2023 |
| 29 Aug 2022 | $0.4518 | 0.00% | Final | 15 Sep 2022 |
| 21 Feb 2022 | $0.3367 | 0.00% | Interim | 09 Mar 2022 |
| 30 Aug 2021 | $0.5944 | 0.00% | Final | 16 Sep 2021 |
| 22 Feb 2021 | $0.4190 | 0.00% | Interim | 10 Mar 2021 |
| 31 Aug 2020 | $0.3811 | 0.00% | Final | 17 Sep 2020 |
| 24 Feb 2020 | $0.3288 | 0.00% | Interim | 12 Mar 2020 |
| 16 Aug 2019 | $0.3833 | 0.00% | Final | 05 Sep 2019 |
| 22 Feb 2019 | $0.2905 | 0.00% | Interim | 14 Mar 2019 |
| 24 Aug 2018 | $0.3414 | 0.00% | Final | 13 Sep 2018 |
| 16 Feb 2018 | $0.2588 | 44.13% | Interim | 08 Mar 2018 |
| 18 Aug 2017 | $0.2998 | 0.00% | Final | 08 Sep 2017 |
| 17 Feb 2017 | $0.2638 | 0.00% | Interim | 10 Mar 2017 |
| 19 Aug 2016 | $0.3097 | 0.00% | Final | 08 Sep 2016 |
| 11 Feb 2016 | $0.2795 | 0.00% | Interim | 10 Mar 2016 |
| 13 Aug 2015 | $0.3119 | 0.00% | Final | 10 Sep 2015 |
| 12 Feb 2015 | $0.2567 | 0.00% | Interim | 11 Mar 2015 |
| 26 Feb 2014 | $0.1828 | 0.00% | Interim | 25 Mar 2014 |
| 16 Feb 2012 | $0.1050 | 0.00% | Interim | 14 Mar 2012 |
| 17 Feb 2011 | $0.0980 | 0.00% | Interim | 16 Mar 2011 |
| 31 Aug 2010 | $0.1225 | 0.00% | Final | 29 Sep 2010 |
| 02 Mar 2006 | $0.0630 | 0.00% | Interim | 07 Apr 2006 |
| 26 Sep 2005 | $0.0700 | 0.00% | Final | 18 Oct 2005 |
ANN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Ansell Ltd
Ansell Ltd (ASX: ANN) is a leading global supplier of protective gloves and bodywear for use in healthcare and industrial settings.
The company holds a large number of patents and the majority of sales come from its key branded product ranges. It earns the bulk of its revenue and profit from the healthcare segment and the remainder from its industrial business.
The Australian company has an international manufacturing and distribution footprint and supplies its products via key partners as well as directly across more than 100 countries.
Ansell earns the bulk of its revenue from its North American market segment followed by Europe, the Middle East, and Africa. The Asia-Pacific accounts for a relatively small portion of the company's business.
ANN Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 14 Jan 2026 | $33.85 | $0.01 | 0.03% | 911,663 | $33.71 | $33.88 | $33.31 |
| 13 Jan 2026 | $33.84 | $-0.15 | -0.44% | 163,128 | $34.23 | $34.25 | $33.75 |
| 12 Jan 2026 | $33.99 | $0.50 | 1.49% | 215,453 | $33.75 | $34.26 | $33.74 |
| 09 Jan 2026 | $33.49 | $0.13 | 0.39% | 345,260 | $33.41 | $33.79 | $33.35 |
| 08 Jan 2026 | $33.36 | $-2.22 | -6.24% | 445,834 | $35.14 | $35.16 | $32.96 |
| 07 Jan 2026 | $35.58 | $0.34 | 0.96% | 114,585 | $35.07 | $35.75 | $35.07 |
| 06 Jan 2026 | $35.24 | $-0.36 | -1.01% | 180,415 | $35.34 | $35.58 | $35.12 |
| 05 Jan 2026 | $35.60 | $0.40 | 1.14% | 197,938 | $35.08 | $35.81 | $34.92 |
| 02 Jan 2026 | $35.20 | $0.19 | 0.54% | 71,601 | $35.19 | $35.20 | $34.88 |
| 31 Dec 2025 | $35.01 | $-0.10 | -0.28% | 91,827 | $34.90 | $35.42 | $34.61 |
| 30 Dec 2025 | $35.11 | $0.01 | 0.03% | 104,839 | $35.46 | $35.46 | $34.86 |
| 29 Dec 2025 | $35.10 | $-0.29 | -0.82% | 92,493 | $35.13 | $35.41 | $35.03 |
| 24 Dec 2025 | $35.39 | $-0.18 | -0.51% | 71,419 | $35.42 | $35.49 | $35.14 |
| 23 Dec 2025 | $35.57 | $-0.27 | -0.75% | 213,066 | $35.61 | $36.15 | $35.21 |
| 22 Dec 2025 | $35.84 | $0.36 | 1.01% | 233,736 | $35.84 | $36.16 | $35.78 |
| 19 Dec 2025 | $35.48 | $0.61 | 1.75% | 557,910 | $34.84 | $35.48 | $34.83 |
| 18 Dec 2025 | $34.87 | $-0.36 | -1.02% | 345,307 | $35.14 | $35.14 | $34.55 |
| 17 Dec 2025 | $35.23 | $-0.68 | -1.89% | 311,453 | $36.00 | $36.10 | $35.14 |
| 16 Dec 2025 | $35.91 | $-0.08 | -0.22% | 204,060 | $35.90 | $36.23 | $35.59 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 10 Nov 2025 | Neil Salmon | Issued | 135,406 | $4,896,280 |
Issue of securities. 4,16,296 Rights, As per announcement on 14-11-2025
|
| 14 Oct 2025 | Neil Salmon | Issued | 7,548 | $248,706 |
Issue of securities.
|
| 14 Oct 2025 | Neil Salmon | Issued | 20,257 | $667,468 |
Issue of securities.
|
| 24 Sep 2025 | Debra (Debbie) Goodin | Buy | 887 | $29,608 |
On-market trade.
|
| 25 Aug 2025 | Neil Salmon | Transfer | 3,400 | $117,402 |
As advised by the company. Reallocation of a proportion
|
| 25 Aug 2025 | Neil Salmon | Issued | 5,653 | $195,198 |
Issue of securities. 1,40,445 Rights
|
| 25 Aug 2025 | Neil Salmon | Sell | 8,698 | $300,341 |
As advised by the company. to cover tax obligations
|
| 25 Aug 2025 | Neil Salmon | Transfer | 3,400 | $117,402 |
As advised by the company. Reallocation of a proportion
|
| 25 Aug 2025 | Neil Salmon | Exercise | 64,535 | $2,228,393 |
Conversion of securities. 134792 Rights
|
| 25 Aug 2025 | Neil Salmon | Issued | 64,535 | $2,228,393 |
Conversion of securities.
|
| 12 Mar 2025 | Debra (Debbie) Goodin | Buy | 2,908 | $97,912 |
On-market trade.
|
| 26 Feb 2025 | Debra (Debbie) Goodin | Buy | 426 | $14,952 |
On-market trade.
|
| 21 Feb 2025 | Debra (Debbie) Goodin | Buy | 1,427 | $50,658 |
On-market trade.
|
| 12 Feb 2025 | Nigel Garrard | Buy | 1,000 | $36,700 |
On-market trade.
|
| 12 Feb 2025 | Neil Salmon | Issued | 68,182 | $2,477,052 |
Issue of securities. 199,327 - PSRs
|
| 12 Feb 2025 | Neil Salmon | Issued | 21,340 | $599,440 |
Issue of securities.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Nigel David Garrard | Non-Executive DirectorNon-Executive Chairman | Mar 2020 |
Mr Garrard is an experienced executive with a successful track record across FMCG and Industrial/ Manufacturing sectors. He has 20 years of experience as an ASX-listed CEO across three companies. In 2019, he retired as Managing Director and CEO of Orora Limited. He led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013. He brings broad international experience across listed, not-for-profit, governance, private and industry entities. He is Chair of the Governance Committee and Share Buyback Sub-Committee and member of the Human Resources Committee and M&A Sub- Committee.
|
| Mr William G Reilly | Non-Executive Director | Oct 2017 |
Mr Reilly has over 35 years of experience as an in-house lawyer. He has served with three Chief Executive Officers and has played pivotal roles leading many of Ansells corporate strategic and legal initiatives, including M&A, litigation and the successful intellectual property strategy. He has also overseen the Global Compliance and Risk functions, acted as interim head of Human Resources, leader of the Regulatory function and joint Company Secretary. Prior to joining Ansell, he held senior legal positions at C. R. Bard, Inc., The Hertz Corporation and McKesson Corporation. In 2016, he was named on the Financial Times first ever Global GC 30 List. He is Member of the Sustainability and Risk Committee, the Human Resources Committee, the Governance Committee and the M&A Sub Committee.
|
| Ms Debra (Debbie) Lyn Goodin | Non-Executive Director | Dec 2022 |
Ms Goodin is a former executive who has global experience in operations, finance, M&A and corporate services, and has worked in both the public and private sectors. In 2014 she completed a 22 month contract role with Downer Group (ASX 100) as Divisional CEO/ COO of Downers two consulting subsidiary companies in New Zealand and Australia. Prior to this she was the Global COO of Coffey International where she led a range of engineering consulting businesses in the areas of mining, geotechnics, environment and international development. She is Member of the Compliance Committee, Human Resources Committee, Governance Committee and Share Buyback Sub-Committee.
|
| Ms Leslie A Desjardins | Non-Executive Director | Nov 2015 |
Mrs Desjardins is a former international finance executive with experience in business performance and growth. She was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the United States and Australia, including Chief Financial Officer GM Holden, Controller for GM North America and Finance Director for GMs manufacturing facilities in North America. Mrs Desjardins has experience in finance, M&A, strategy, government relations and global operations. She is Chair of the Compliance Committee, member of the Human Resources Committee, the Governance Committee, M&A Sub- Committee and Share Buyback Sub-Committee.
|
| Mrs Christina Stercken | Non-Executive Director | Oct 2017 |
Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, she helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A and operational excellence in growth markets. Before joining EAC, she served as Managing Director Corporate Finance M&A of Siemens AG. Among other management positions within Siemens AG, she was responsible for the Siemens Task Force China and Head of Public Sector Business Unit at Siemens Business Services. Mrs Stercken started her career in Marketing at BMW Pty. Ltd, South Africa. In her function as Vice Chair of Myanmar Foundation, Munich, Mrs Stercken supports social projects in Myanmar. She is Chair of the Sustainability and Risk Committee and M&A Sub-Committee and member of the Compliance Committee and Governance Committee.
|
| Ms Christine Yingli Yan | Non-Executive Director | Feb 2019 |
Ms Yan is an experienced executive who has had a distinguished career at Stanley Black & Decker. She has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems and more recently, President of Asia and Vice President of Integration. Ms Yan brings a broad range of general management experience across different geographies, as well as experience in innovation, business development, sales, digital transformation and marketing in the business-to business industry. She is Chair of the Human Resources Committee and a member of the Sustainability and Risk Committee and the Governance Committee.
|
| Mr Neil Salmon | Chief Executive OfficerManaging Director | Sep 2021 |
Mr Salmon had more than 20 years of professional experience, gained working across a range of roles in a diverse group of international businesses. He spent the first 17 years of his career with Imperial Chemical Industries (ICI) primarily in finance roles based in the UK, South Africa, the USA and Singapore before serving as Chief Financial Officer of Innophos in New Jersey, USA. Having led Ansells 7,500 strong Industrial Segment workforce through a challenging global economic climate, he put in place the key strategies that have allowed the company to pursue its growth trajectory in recent times, notably at the onset of the COVID-19 pandemic. As CEO, he oversees the Companys further strategic development, with a focus on continued innovation and increased sustainability.
|
| Mr Randy Stone | Non-Executive Director | Aug 2025 |
Mr Stone is a executive who has global experience. Mr Stone had an executive career including positions with Avantor (NYSE: AVTR) and DuPont (NYSE: DD). Mr Stone is currently a Member of the Board of Directors for CTS Corporation, a NYSE listed company that designs and manufactures smart solutions for various markets.
|
| Ms Catherine Stribley | VP Corporate Governance & Social ResponsibilityCompany Secretary | Apr 2017 |
-
|
| Brian C Montgomery | Chief Financial Officer |
-
|
|
| Catherine Stribley | VP Corporate Governance & Social ResponsibilityCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 49,301,225 | 33.78% |
| Citicorp Nominees Pty Limited | 27,700,513 | 18.98% |
| J P Morgan Nominees Australia Pty Limited | 25,379,687 | 17.39% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 4,255,244 | 2.92% |
| BNP Paribas Noms Pty Ltd | 2,181,828 | 1.49% |
| National Nominees Limited | 1,674,905 | 1.15% |
| HSBC Custody Nominees (Australia) Limited <Ntcomnwlth Super Corp A/C> | 1,639,115 | 1.12% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 1,018,423 | 0.70% |
| Cpu Share Plans Pty Ltd | 737,317 | 0.51% |
| Netwealth Investments Limited <Wrap Services A/C> | 597,253 | 0.41% |
| BBNP Paribas Nominees Pty Ltd <Agency Lending Collateral> | 502,700 | 0.34% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 382,690 | 0.26% |
| Ioof Investment Services Limited <Ips Superfund A/C> | 373,230 | 0.26% |
| Citicorp Nominees Pty Limited <143212 Nmmt Ltd A/C> | 289,530 | 0.20% |
| Netwealth Investments Limited <Super Services A/C> | 252,774 | 0.17% |
| The Manly Hotels Pty Limited | 224,191 | 0.15% |
| BNP Paribas Noms (Nz) Ltd | 217,646 | 0.15% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 172,325 | 0.12% |
| Ioof Investment Services Limited <Ioof Idps A/C> | 139,338 | 0.10% |
| Dixson Trust Pty Limited | 114,561 | 0.07% |